Cutting edge:: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation

被引:66
作者
Sarkar, Chandrani
Das, Shamik
Chakroborty, Debanjan
Chowdhury, Uttio Roy
Basu, Biswarup
Dasgupta, Partha Sarathi
Basu, Sujit
机构
[1] Signal Transduct & Biogen Amines Lab, Kolkata 700026, W Bengal, India
[2] Chittaranjan Natl Canc Inst, Dept Med Oncol, Kolkata, W Bengal, India
[3] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
关键词
D O I
10.4049/jimmunol.177.11.7525
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The neurotransmitter dopamine (DA) is an important regulator of human T cell functions. Although it has been observed that DA, by acting through the D-1/D-5, D-2, and D-3 receptors, can activate resting T cells by stimulating the release of cytokines and the expression of surface integrins and also inhibit the proliferation of activated T cells by down-regulating nonreceptor tyrosine kinases, there is not yet a report indicating the functional significance of the D-4 DA receptors present in these cells. The present work,for the first time, demonstrates that the stimulation of D-4 DA receptors in human T cells induces T cell quiescence by up-regulating lung Kruppel-like factor-2 expression through the inhibition of ERK1/ERK2 phosphorylation. These results reveal a new link between the nervous system and T cell quiescence and indicate that D-4 DA receptor agonists may have a therapeutic value in diseases with uncontrolled T cell proliferation. The Journal of Immunology, 2006, 177: 7525-7529.
引用
收藏
页码:7525 / 7529
页数:5
相关论文
共 28 条
[1]   Dopamine, a neurotransmitter, influences the immune system [J].
Basu, S ;
Dasgupta, PS .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (02) :113-124
[2]   Clinical review: Immunomodulatory effects of dopamine in general inflammation [J].
Beck, GC ;
Brinkkoetter, P ;
Hanusch, C ;
Schulte, J ;
van Ackern, K ;
van der Woude, FJ ;
Yard, BA .
CRITICAL CARE, 2004, 8 (06) :485-491
[3]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[4]   Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both [J].
Besser, MJ ;
Ganor, Y ;
Levite, M .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 169 (1-2) :161-171
[5]   Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway [J].
Buckley, AF ;
Kuo, CT ;
Leiden, JM .
NATURE IMMUNOLOGY, 2001, 2 (08) :698-704
[6]   Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: Phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression [J].
Chen, CH ;
Zhang, DH ;
LaPorte, JM ;
Ray, A .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5597-5605
[7]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595
[8]   Differential role for IL-7 in inducing lung Kruppel-like factor (Kruppel-like factor 2) expression by naive versus activated T cells [J].
Endrizzi, BT ;
Jameson, SC .
INTERNATIONAL IMMUNOLOGY, 2003, 15 (11) :1341-1348
[9]   Neural-immune interactions in health and disease [J].
Eskandari, F ;
Sternberg, EM .
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 :20-27
[10]   Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells [J].
Ghosh, MC ;
Mondal, AC ;
Basu, S ;
Banerjee, S ;
Majumder, J ;
Bhattacharya, D ;
Dasgupta, PS .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (07) :1019-1026